{"id":"arm-b-blocks-therapy-drug","safety":{"commonSideEffects":[{"rate":null,"effect":"Bradycardia"},{"rate":null,"effect":"Hypotension"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Beta-blockers work by antagonizing beta-adrenergic receptors, thereby decreasing heart rate, blood pressure, and myocardial oxygen demand. In the context of acute leukemia therapy (likely as a supportive care agent), beta-blockade may help manage cardiovascular stress and arrhythmias associated with intensive chemotherapy regimens.","oneSentence":"ARM B: Blocks Therapy Drug inhibits beta-adrenergic receptors to reduce sympathetic nervous system activity in acute leukemia treatment.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:26.952Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute leukemia (supportive care in phase 3 trial)"}]},"trialDetails":[{"nctId":"NCT05748171","phase":"PHASE2","title":"A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL","status":"RECRUITING","sponsor":"Pfizer","startDate":"2023-05-17","conditions":"ACUTE LYMPHOBLASTIC LEUKEMIA","enrollment":100},{"nctId":"NCT01042379","phase":"PHASE2","title":"I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer","status":"RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2010-03-01","conditions":"Breast Neoplasms, Breast Cancer, Breast Tumors","enrollment":5000},{"nctId":"NCT06038539","phase":"PHASE3","title":"Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer","status":"TERMINATED","sponsor":"Biocon Biologics UK Ltd","startDate":"2025-01-06","conditions":"HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients","enrollment":55},{"nctId":"NCT07454954","phase":"NA","title":"The Effect of Blood Flow Restriction Training Combined With Transcranial Magnetic Stimulation on Limb Function in Hemiplegic Patients After Stroke","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Zhengzhou University","startDate":"2026-03-01","conditions":"Stroke, Hemiplegia","enrollment":69},{"nctId":"NCT06977581","phase":"PHASE2","title":"A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-05-20","conditions":"Asthma","enrollment":252},{"nctId":"NCT07402473","phase":"PHASE2","title":"EUREKA Study:Phase 2 Study to Optimize Neoadjuvant Therapy in HER2-positive Early-stage Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-03-01","conditions":"HER2-positive Early-stage Breast Cancer","enrollment":50},{"nctId":"NCT03965468","phase":"PHASE2","title":"Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"ETOP IBCSG Partners Foundation","startDate":"2019-11-19","conditions":"Non-small Cell Lung Cancer, Stage IV, Oligometastasis","enrollment":96},{"nctId":"NCT06024096","phase":"PHASE4","title":"Systems Biological Assessment of Statin Effect on Vaccine Responses","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-09-20","conditions":"Vaccine Response","enrollment":63},{"nctId":"NCT05317000","phase":"PHASE2","title":"5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC","status":"RECRUITING","sponsor":"Barbara Burtness","startDate":"2023-03-23","conditions":"Squamous Cell Carcinoma of Head and Neck","enrollment":50},{"nctId":"NCT07227727","phase":"","title":"Endothelial Dysfunction After SCI","status":"RECRUITING","sponsor":"Craig Hospital","startDate":"2025-07-31","conditions":"Spinal Cord Injuries, Endothelial Dysfunction","enrollment":40},{"nctId":"NCT03520686","phase":"PHASE3","title":"Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2018-05-18","conditions":"Non Small Cell Lung Cancer","enrollment":1538},{"nctId":"NCT04435288","phase":"PHASE3","title":"Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2020-08-24","conditions":"Peripheral Spondyloarthritis","enrollment":90},{"nctId":"NCT04245514","phase":"PHASE2","title":"Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Swiss Cancer Institute","startDate":"2020-07-15","conditions":"Non-small Cell Lung Cancer, NSCLC","enrollment":90},{"nctId":"NCT04478292","phase":"PHASE3","title":"A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy","status":"RECRUITING","sponsor":"Shanghai Children's Medical Center","startDate":"2021-03-01","conditions":"Hepatoblastoma","enrollment":330},{"nctId":"NCT05572957","phase":"NA","title":"LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-10-14","conditions":"Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block","enrollment":50},{"nctId":"NCT04747912","phase":"PHASE2","title":"Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2021-03-02","conditions":"Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia","enrollment":25},{"nctId":"NCT03158129","phase":"PHASE2","title":"Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-06-16","conditions":"Stage I Lung Non-Small Cell Cancer AJCC v7, Stage IA Lung Non-Small Cell Carcinoma AJCC v7, Stage IB Lung Non-Small Cell Carcinoma AJCC v7","enrollment":101},{"nctId":"NCT06813079","phase":"PHASE2","title":"Using Tumor Models to Determine Treatments","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-02-17","conditions":"Pancreatic Ductal Carcinoma, Advanced Cancer, Epithelial Tumor","enrollment":25},{"nctId":"NCT06630611","phase":"PHASE2","title":"Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)","status":"RECRUITING","sponsor":"Vall d'Hebron Institute of Oncology","startDate":"2025-01-15","conditions":"Melanoma, Non Small Cell Lung Cancer, Cervical Cancer","enrollment":40},{"nctId":"NCT06603051","phase":"NA","title":"The Effect of Pre-Operative Cryoneurolysis on Post-Operative Narcotic Consumption in Patients Undergoing Autograft ACL Reconstruction","status":"RECRUITING","sponsor":"Virtua Health, Inc.","startDate":"2024-08-28","conditions":"ACL Repair","enrollment":20},{"nctId":"NCT06786507","phase":"","title":"A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Helwan University","startDate":"2025-05-15","conditions":"Ulcerative Colitis (UC)","enrollment":100},{"nctId":"NCT01228331","phase":"PHASE2, PHASE3","title":"Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2010-10","conditions":"Leukemia","enrollment":745},{"nctId":"NCT02942277","phase":"PHASE1","title":"Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-10-21","conditions":"Malaria","enrollment":301},{"nctId":"NCT05221645","phase":"PHASE2","title":"Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southampton","startDate":"2022-06-27","conditions":"Diffuse Large B Cell Lymphoma","enrollment":65},{"nctId":"NCT04081545","phase":"PHASE3","title":"Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery","status":"COMPLETED","sponsor":"Christine Oryhan","startDate":"2019-12-24","conditions":"Opioid Use, Unspecified, Bariatric Surgery Candidate, Anesthesia","enrollment":181},{"nctId":"NCT03409198","phase":"PHASE2","title":"Phase IIb Study Evaluating Immunogenic Chemotherapy Combined with Ipilimumab and Nivolumab in Breast Cancer","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2018-01-21","conditions":"Breast Cancer, Hormone Receptor Positive Tumor, Metastatic Breast Cancer","enrollment":82},{"nctId":"NCT02049437","phase":"PHASE1, PHASE2","title":"AIDS 347: IL-6 Blockade in Treated HIV Infection","status":"COMPLETED","sponsor":"Case Western Reserve University","startDate":"2014-08","conditions":"HIV Infections","enrollment":34},{"nctId":"NCT05284539","phase":"PHASE2","title":"Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer","status":"RECRUITING","sponsor":"Hunan Province Tumor Hospital","startDate":"2022-04-01","conditions":"Non Small Cell Lung Cancer","enrollment":760},{"nctId":"NCT02182687","phase":"PHASE2","title":"Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant","status":"COMPLETED","sponsor":"Lahey Clinic","startDate":"2014-06","conditions":"Hepatocellular Carcinoma, HCC","enrollment":60},{"nctId":"NCT06211452","phase":"PHASE3","title":"Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Grupo Argentino de Tratamiento de la Leucemia Aguda","startDate":"2007-08-01","conditions":"AML, Pediatric AML","enrollment":258},{"nctId":"NCT06175845","phase":"NA","title":"Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma","status":"NOT_YET_RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2024-02","conditions":"Cholangiocarcinoma, Klatskin Tumor, Bile Duct Cancer","enrollment":130},{"nctId":"NCT05446597","phase":"NA","title":"SMART Concussion Trial: Symptom Management vs Alternative Randomized Treatment of Concussion Trial","status":"UNKNOWN","sponsor":"University of Calgary","startDate":"2023-04-10","conditions":"Mild Traumatic Brain Injury, Headaches Posttraumatic, Neck Pain","enrollment":164},{"nctId":"NCT05985707","phase":"PHASE2","title":"KN026 Plus Chemotherapy ± KN-046 in HER2 Positive Colorectal Cancer and Biliary Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Peking University Cancer Hospital & Institute","startDate":"2023-08-15","conditions":"HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer","enrollment":80},{"nctId":"NCT03121677","phase":"PHASE1","title":"Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2018-10-16","conditions":"Follicular Lymphoma","enrollment":4},{"nctId":"NCT02238496","phase":"PHASE1","title":"Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas","status":"COMPLETED","sponsor":"Andrew B Lassman, MD","startDate":"2014-12-08","conditions":"Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma","enrollment":10},{"nctId":"NCT05558878","phase":"NA","title":"Effect of Ambroxol in Diabetic Peripheral Neuropathy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2022-10-01","conditions":"Diabetic Neuropathy Peripheral","enrollment":80},{"nctId":"NCT01887041","phase":"PHASE4","title":"Quality of Life After Biliodigestive Anastomosis (BDA) or Stents to Treat Biliary Obstruction in Pancreas Cancer","status":"TERMINATED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2010-01","conditions":"Local Tumor Spread, Advanced Cancer, Metastasized","enrollment":24},{"nctId":"NCT02684461","phase":"PHASE2","title":"Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2016-09-13","conditions":"Non Small Cell Lung Cancer","enrollment":20},{"nctId":"NCT05366062","phase":"PHASE2","title":"ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab","status":"NOT_YET_RECRUITING","sponsor":"Epitopoietic Research Corporation","startDate":"2022-07-01","conditions":"Glioma, Malignant","enrollment":28},{"nctId":"NCT03161223","phase":"PHASE1, PHASE2","title":"Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2018-05-30","conditions":"Lymphoma, T-Cell","enrollment":148},{"nctId":"NCT05081115","phase":"","title":"Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging","status":"RECRUITING","sponsor":"Fatebenefratelli Hospital","startDate":"2021-04-01","conditions":"Coronary Artery Disease, Heart Failure, Hypertrophic Cardiomyopathy","enrollment":10000},{"nctId":"NCT05039658","phase":"PHASE1","title":"Efficacy and Safety of IBI110 Single Agent and in Combination With Sintilimab in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL)","status":"UNKNOWN","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","startDate":"2021-09-27","conditions":"DLBCL","enrollment":50},{"nctId":"NCT03846583","phase":"PHASE1","title":"Tucatinib + Abemaciclib + Herceptin for HER2+ MBC","status":"WITHDRAWN","sponsor":"Dana-Farber Cancer Institute","startDate":"2020-06-28","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT04113135","phase":"NA","title":"The Utilization of Yoga as a Therapeutic Tool to Promote Physical Activity Behavior Change and Improved Postural Control in Individuals With Multiple Sclerosis","status":"WITHDRAWN","sponsor":"Winston Salem State University","startDate":"2020-01-01","conditions":"Multiple Sclerosis","enrollment":""},{"nctId":"NCT04537130","phase":"PHASE1","title":"Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge","status":"UNKNOWN","sponsor":"Instituto Oncológico Dr Rosell","startDate":"2020-12-01","conditions":"Pulmonary Fibrosis, Covid19","enrollment":40},{"nctId":"NCT04392427","phase":"PHASE3","title":"New Antiviral Drugs for Treatment of COVID-19","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2020-10","conditions":"COVID, Drug Effect","enrollment":100},{"nctId":"NCT03840122","phase":"NA","title":"ACB + IPACK Block With or Without Local Infiltration in RA-TKA","status":"WITHDRAWN","sponsor":"University of Louisville","startDate":"2019-10-08","conditions":"Knee Arthropathy","enrollment":""},{"nctId":"NCT03853720","phase":"NA","title":"Combined and Simultaneous Approach for the Treatment of High-risk Gastric Varices Using B-RTO and EVO","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2019-04","conditions":"Gastric Varices Bleeding, Gastric Varix","enrollment":20},{"nctId":"NCT02488694","phase":"PHASE2","title":"Maintaining ERBB Blockade in EGFR-mutated Lung Cancer","status":"TERMINATED","sponsor":"AIO-Studien-gGmbH","startDate":"2015-11","conditions":"Non-small-cell Lung Cancer With Somatic EGFR Mutations","enrollment":4},{"nctId":"NCT00554164","phase":"PHASE3","title":"Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas","status":"COMPLETED","sponsor":"University Hospital, Essen","startDate":"2007-11","conditions":"Lymphoma, High-grade","enrollment":1073},{"nctId":"NCT01222117","phase":"PHASE2","title":"A Study of Intra-thrombus Plasmin (Human) In Acute Peripheral Arterial Occlusion","status":"COMPLETED","sponsor":"Grifols Therapeutics LLC","startDate":"2010-12","conditions":"Acute Peripheral Arterial Occlusion","enrollment":174},{"nctId":"NCT01978873","phase":"PHASE3","title":"Efficacy Study Evaluating Chemotherapy in Prostate Cancer","status":"UNKNOWN","sponsor":"Örebro University, Sweden","startDate":"2012-11","conditions":"Prostate Cancer","enrollment":400},{"nctId":"NCT02729506","phase":"PHASE4","title":"Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2016-01","conditions":"Hepatocellular Carcinoma","enrollment":150},{"nctId":"NCT01965418","phase":"PHASE4","title":"A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical Trial","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2013-09","conditions":"Liver Fibrosis, Chronic Hepatitis B","enrollment":1000},{"nctId":"NCT00764907","phase":"PHASE3","title":"Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia","status":"UNKNOWN","sponsor":"University Hospital, Motol","startDate":"2002-11","conditions":"Leukemia","enrollment":4000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"ARM B: Blocks Therapy Drug","genericName":"ARM B: Blocks Therapy Drug","companyName":"Grupo Argentino de Tratamiento de la Leucemia Aguda","companyId":"grupo-argentino-de-tratamiento-de-la-leucemia-aguda","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ARM B: Blocks Therapy Drug inhibits beta-adrenergic receptors to reduce sympathetic nervous system activity in acute leukemia treatment. Used for Acute leukemia (supportive care in phase 3 trial).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}